These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 37197486)

  • 1. Comprehensive bioinformatics analysis on exportins in lung adenocarcinoma and lung squamous cell carcinoma.
    Pan M; Huang P; Li L; Lei P; Fang L; Zhao L; Li Y; Huang S; Luo W
    J Thorac Dis; 2023 Apr; 15(4):1872-1891. PubMed ID: 37197486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. System analysis of
    Situ Y; Gao R; Lei L; Deng L; Xu Q; Shao Z
    Int J Biol Markers; 2022 Jun; 37(2):158-169. PubMed ID: 35254116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression, Prognosis and Gene Regulation Network of NFAT Transcription Factors in Non-Small Cell Lung Cancer.
    Ma J; Du R; Huang Y; Zhong W; Gui H; Mao C; Song X; Lu J
    Pathol Oncol Res; 2021; 27():529240. PubMed ID: 34257525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer Stemness-Based Prognostic Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
    Li N; Li Y; Zheng P; Zhan X
    Front Endocrinol (Lausanne); 2021; 12():755805. PubMed ID: 34745015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation and analysis of expression, prognosis and immune infiltration of WNT gene family in non-small cell lung cancer.
    Wang J; Yang Q; Tang M; Liu W
    Front Oncol; 2022; 12():911316. PubMed ID: 35957916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LINC00628 is differentially expressed between lung adenocarcinoma and squamous cell carcinoma and is associated with the prognosis of NSCLC.
    Liu T; Xu S; Liu X
    Oncol Lett; 2022 Feb; 23(2):55. PubMed ID: 34992687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of NR3C2 as a functional diagnostic and prognostic biomarker and potential therapeutic target in non-small cell lung cancer.
    Sun YY; Gao HC; Guo P; Sun N; Peng C; Cheng ZH; Gu J; Liu JY; Han F
    Cancer Innov; 2024 Aug; 3(4):e122. PubMed ID: 38948253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Combined Detection of Immune Genes for Predicting the Prognosis of Patients With Non-Small Cell Lung Cancer.
    Tian WJ; Liu SS; Li BR
    Technol Cancer Res Treat; 2020; 19():1533033820977504. PubMed ID: 33256552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Identification of differentially expressed genes between lung adenocarcinoma and squamous cell carcinoma using transcriber signature analysis].
    Peng S; Li X; Liu Q; Zhang Y; Zou L; Gong X; Wang M; Ma X
    Nan Fang Yi Ke Da Xue Xue Bao; 2019 Jun; 39(6):641-649. PubMed ID: 31270041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced Glycation End Products' Receptor DNA Methylation Associated with Immune Infiltration and Prognosis of Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
    Yang J; Lin M; Zhang M; Wang Z; Lin H; Yu Y; Zheng Q; Chen X; Wu Y; Yao Q; Li J
    Genet Res (Camb); 2023; 2023():7129325. PubMed ID: 37497166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effect of GLUT1 on the Survival Rate and Immune Cell Infiltration of Lung Adenocarcinoma and Squamous Cell Carcinoma: A Meta and Bioinformatics Analysis.
    Zhang G; Dong R; Kong D; Liu B; Zha Y; Luo M
    Anticancer Agents Med Chem; 2022; 22(2):223-238. PubMed ID: 34238200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KIAA1199 Correlates With Tumor Microenvironment and Immune Infiltration in Lung Adenocarcinoma as a Potential Prognostic Biomarker.
    Shen X; Mo X; Tan W; Mo X; Li L; Yu F; He J; Deng Z; Xing S; Chen Z; Yang J
    Pathol Oncol Res; 2022; 28():1610754. PubMed ID: 36419650
    [No Abstract]   [Full Text] [Related]  

  • 13. Identification of Potential Key Genes and Prognostic Biomarkers of Lung Cancer Based on Bioinformatics.
    Cai K; Xie Z; Liu Y; Wu J; Song H; Liu W; Wang X; Xiong Y; Gan S; Sun Y
    Biomed Res Int; 2023; 2023():2152432. PubMed ID: 36714024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CC Chemokine Receptors in Lung Adenocarcinoma: The Inflammation-Related Prognostic Biomarkers and Immunotherapeutic Targets.
    Liu F; Wu H
    J Inflamm Res; 2021; 14():267-285. PubMed ID: 33574689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PHD3 as a Prognosis Marker and its Relationship with Immune Infiltration in Lung Adenocarcinoma.
    Wang L; Zhong Y; Wang G; An H; Gao Q; Ye Y
    Comb Chem High Throughput Screen; 2022; 25(13):2255-2263. PubMed ID: 35088661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased zinc-fingers and homeoboxes family expression was associated with unfavorable outcomes and immune infiltration in lung adenocarcinoma.
    Tao D; Tan J; Zhang N; Yang D; Jiang Y; Zhou W; Wang Y; Wu Y
    Transl Cancer Res; 2023 Jun; 12(6):1422-1440. PubMed ID: 37434685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
    Li N; Wang J; Zhan X
    Front Immunol; 2021; 12():752643. PubMed ID: 34887858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of PTGES3 on the Prognosis and Immune Regulation in Lung Adenocarcinoma.
    Jiang W; Wei Q; Xie H; Wu D; He H; Lv X
    Anal Cell Pathol (Amst); 2023; 2023():4522045. PubMed ID: 37416927
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Yi C; Zang N; Gao L; Ren F
    Aging (Albany NY); 2024 May; 16(11):9498-9517. PubMed ID: 38819947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic and immune infiltration role of ITGB superfamily members in non-small cell lung cancer.
    Wu J; Wang W; Li Z; Ye X
    Am J Transl Res; 2022; 14(9):6445-6466. PubMed ID: 36247270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.